Semaglutide Shows No Link to Lower Cirrhosis or HCC Risk Tags GLP-1 agonists Read more about Semaglutide Shows No Link to Lower Cirrhosis or HCC Risk
SGLT2i Linked to Lower Risk of ESKD in Nephrotic-Range Proteinuria Tags DPP-4 inhibitors SGLT-2 Inhibitor Read more about SGLT2i Linked to Lower Risk of ESKD in Nephrotic-Range Proteinuria
GLP-1RAs and SGLT2i Show Favorable Liver Outcome Profiles in T2DM Tags Sulphonylureas GLP-1 agonists DPP-4 inhibitors Thiazolidinediones Read more about GLP-1RAs and SGLT2i Show Favorable Liver Outcome Profiles in T2DM
Decision Support Tool Increases SGLT2i, GLP-1RA Use in T2DM Care Tags hBA1c GLP-1 agonists SGLT-2 Inhibitor Read more about Decision Support Tool Increases SGLT2i, GLP-1RA Use in T2DM Care
A Case of Hyperosmolar Hyperglycemic State With Acute Kidney Injury and Subsequent Hypoglycemia Tags Hyperglycemia hyperosmolar state Hypoglycemia hBA1c Insulin syringes Sulphonylureas Biguanide Read more about A Case of Hyperosmolar Hyperglycemic State With Acute Kidney Injury and Subsequent Hypoglycemia
Tirzepatide Shows Lower CV Events in Indirect Placebo Analysis Tags Coronary artery disease GLP-1 agonists Read more about Tirzepatide Shows Lower CV Events in Indirect Placebo Analysis
Oral Semaglutide Improves HbA1c and Weight After DPP-4i Tags hBA1c GLP-1 agonists DPP-4 inhibitors Read more about Oral Semaglutide Improves HbA1c and Weight After DPP-4i
Cost and Outcomes Vary Across DPP-4 and Metformin Combinations Tags DPP-4 inhibitors Biguanide Read more about Cost and Outcomes Vary Across DPP-4 and Metformin Combinations
Once-Weekly Trelagliptin Gains Favor in Clinical Practice Tags DPP-4 inhibitors Read more about Once-Weekly Trelagliptin Gains Favor in Clinical Practice
Which Diabetes Drugs Perform Best on CGM? GRADE Offers Answers Tags Hypoglycemia hBA1c Long acting GLP-1 agonists DPP-4 inhibitors Read more about Which Diabetes Drugs Perform Best on CGM? GRADE Offers Answers